✅ Empowering drug discovery with advanced computational solutions.
We develop and apply innovative in silico tools to accelerate drug research and development, combining bioinformatics, statistical thermodynamics, and structural biology.
✅ From in-depth biomolecular mechanism analysis to protein-protein interaction studies.
We investigate traditional and biotechnological drugs, including small molecules, peptides, proteins, and monoclonal antibodies (mAbs), identifying targets and off-targets at the proteome scale to uncover key molecular mechanisms driving therapeutic and adverse effects, optimizing their development.
✅ Collaborating with biotech, pharma, and academia.
We actively engage in research and development projects, driving innovation in drug and biopharmaceutical development. Our work has also led to publications in peer-reviewed journals and presentations at international biotech and pharma conferences, contributing to the advancement of the field.
✅ Innovative services for the future of drug R&D.
Through our integrated approach, we reduce the risk of failure in preclinical and clinical phases, supporting the development of safer and more effective therapies.
🟢 Stay tuned! We are working to take our technology to the next level.
Download our comprehensive presentation to discover SPILLO’s SERVICES and EXPERIMENTAL VALIDATIONS featured in peer-reviewed journals [PDF – DOWNLOAD]. For more information, contact us at: info@spillo.ch